Biomax Informatics Investing Big to Develop a Knowledge Solution for Mental Health

Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to transfer its successful systems medicine approach from respiratory and chronic diseases to mental health. The European Commission is co-financing this step with €650,000 as part of the METSY project. In the project, Biomax will provide the knowledge management platform and data integration for consortium partners from industry, research and clinics who are searching for associations between psychotic disorders, lipid metabolism and metabolism-related diseases such as obesity and diabetes.

Biomax will provide their BioXM™ Knowledge Management Environment to integrate and explore existing knowledge sources about brain structure and function, extend them with information about psychosis and genetic factors derived from the BioLT™ literature-mining software, and combine them with data generated within the METSY project itself including brain imaging (combined MRI and PET), metabolite profiling, and clinical data from approximately 500 patients recruited at four sites in Spain, the United Kingdom and Finland.

The resulting semantic network of psychosis-specific knowledge - generated from associations between structures, functions and molecules (genes, proteins, metabolites, etc.) - can be overlaid with patient-specific data. The standardization of information and data provided by the BioXM system enables algorithmic analysis and fosters collaboration with external, large-scale brain imaging and systems medicine initiatives. In particular, the METSY partners will use network inference to identify and evaluate multi-modal blood and neuroimaging biomarkers that could be used to predict and monitor psychotic disorders like schizophrenia in the context of metabolic diseases. If specific disease-associated patterns are detected in the project, the network can be further explored for potential explanations. After validation, the knowledge base can be used to build a decision support system to bring the results directly into clinical practice.

About METSY
METSY is a European consortium studying the links between psychotic disorders, lipid metabolism and metabolic co-morbidities such as metabolic syndrome and diabetes. The consortium aims to develop neuroimaging and bioinformatics tools to identify possible diagnostic biomarkers of psychosis.

Funded in part by the EU's Seventh Framework Programme, which provided ~€4.23 million of the €5.94 million total budget, the METSY consortium involves seven members who provide the remainder of the funding: VTT Technical Research Center of Finland, University of Turku, Finland's National Institute for Health and Welfare, Kings College London, Madrid Health Service, Philips Research and Biomax Informatics.

About Biomax Informatics AG
Biomax Informatics AG is a leader in the development of computational solutions for the life sciences. Biomax provides the BioXM™ Knowledge Management Environment and other computational solutions, including the Viscovery® data-mining technology, for better decision making and knowledge management in biomarker identification, patient stratification and targeted medicine.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...